Senior Director, Global Medical Affairs HIV at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Advanced scientific degree (MD, DO, PharmD, PhD, NP/PA) required
  • At least 8+ years of relevant clinical experience required, preferably within the HIV therapeutic area
  • At least 5 years of Pharma industry experience, with prior launch experience preferred
  • People management experience highly preferred
  • Excellent verbal, written, visual communication, and interpersonal skills required

Responsibilities

  • Lead Medical Affairs activities and initiatives pertaining to HIV treatment pipeline, with a focus on long-acting combinations and HIV cure
  • Lead a team of talented professionals (3 at hire) within the GMA HIV Treatment Team
  • Collaborate with Clinical Development, Global Strategic Marketing, Global Value and Access, Medical Affairs Research, affiliate Medical Affairs teams, and other cross-functional teams across varied initiatives including strategic plan development and implementation, evidence generation, scientific resource development, conference activities, and internal training
  • As a therapeutic area expert, serve as the Global Medical Affairs representative on Global Development Teams, Program Strategy Teams, Commercialization Teams and other cross-functional working groups
  • Collaborate to develop the Global Plan of Action and ensure alignment of team activities
  • Support cross-functional data generation efforts, including co-leading or serving as core member of data generation strategy and execution teams
  • Attend major global scientific conferences and lead strategic planning and execution of key conference deliverables/activities
  • Plan and execute Medical Affairs Advisory Programs and support Global Medical Affairs KOL engagement strategy
  • Serve as Medical Affairs lead on select scientific issues/topics using expertise to develop global scientific messages, inform strategy and drive strategic resource development
  • Provide training within the HIV therapeutic area on relevant topics for Medical Affairs and cross-functional personnel
  • Manage projects to completion, anticipating obstacles and difficulties that may arise, resolving them in collaborative manner

Skills

Medical Affairs
HIV Treatment
Clinical Development
Commercialization Strategy
Team Leadership
Medical Education
Advisory Boards
Evidence Generation
Strategic Planning
Patient-Centric Leadership

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI